IPF
Pipeline by Development Stage
Competitive Landscape
9 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (8)
Total enrollment: 1,271 patients across 8 trials
A Trial of AGMB-447 in Participants With Idiopathic Pulmonary Fibrosis
SB17170 Phase 2 Trial in IPF Patients
A Phase 2 Study to Evaluate Safety and Efficacy of AMB-05X in Subjects With Idiopathic Pulmonary Fibrosis
Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis
A PhaseⅠ Study of HW252001 in Healthy Subjects
Phase I Study to Assess Safety, Tolerability, PK and PD of AGMB-447 in Healthy Participants and Participants With IPF
A Study to Evaluate the Safety, Tolerability, PK and PD of HNC1058
Advancing Prevention of Pulmonary Fibrosis
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.